R. González-Iglesias

The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer

R. Berardi, S. Cascinu, P. Conte, 2015, Cell adhesion & migration.

Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges.

M. Gasset, M. Pajares, B. Oesch, 2002, Journal of molecular biology.

Isolated limb perfusion with the tumor‐targeting human monoclonal antibody–cytokine fusion protein L19‐TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma

L. Zardi, D. Neri, A. Maurichi, 2013, Journal of surgical oncology.

Phase I/II study of the tumour-targeting human monoclonal antibody–cytokine fusion protein L19-TNF in patients with advanced solid tumours

R. Berardi, D. Neri, F. Braud, 2013, Journal of Cancer Research and Clinical Oncology.

The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.

F. D. De Braud, K. Miller, G. Curigliano, 2010, European journal of cancer.

A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma

F. D. De Braud, C. Garbe, D. Neri, 2011, Clinical Cancer Research.

Cu2+ binding triggers αBoPrP assembly into insoluble laminar polymers

M. Gasset, M. Pajares, M. Calero, 2004 .

Inter- and Intra-octarepeat Cu(II) Site Geometries in the Prion Protein

M. Gasset, C. Potrich, C. Meneghini, 2004, Journal of Biological Chemistry.